Individualisation of antiviral therapy for chronic hepatitis C.
about
Reasons for nonuse of antiviral treatment in patients with chronic hepatitis C infection and thrombocytopaenia: a retrospective chart review from five European countries.Specific detection of naturally occurring hepatitis C virus mutants with resistance to telaprevir and boceprevir (protease inhibitors) among treatment-naïve infected individuals.Clinical characteristics of null responders to Peg-IFNα2b/ribavirin therapy for chronic hepatitis CInterleukin-28B genotyping by melt-mismatch amplification mutation assay PCR analysis using single nucleotide polymorphisms rs12979860 and rs8099917, a useful tool for prediction of therapy response in hepatitis C patients.Rapid hepatitis C virus divergence among chronically infected individuals.Relevance of the Core 70 and IL-28B polymorphism and response-guided therapy of peginterferon alfa-2a ± ribavirin for chronic hepatitis C of Genotype 1b: a multicenter randomized trial, ReGIT-J study.Infections and the liver.Treatment of HCV in renal transplant patients with peginterferon and ribavirin: long-term follow-up.Hepatitis C Virus Genotype and Subtype Distribution in Patient Specimens Tested at the University of Texas Medical Branch, Galveston, Between January 2011 and November 2014.Influence of psychiatric diagnosis on treatment uptake and interferon side effects in patients with hepatitis C.Gene expression patterns in livers of Hispanic patients infected with hepatitis C virus.
P2860
Q33414392-8C04CBED-83CB-49FE-ACBF-712C708DB880Q34083431-8091706D-BF5B-45E6-9F6A-DED06324DBC9Q34415344-290691D9-49B1-4344-87CA-9EA5F8AF3F56Q35140158-1EA6CF9B-D906-4C8F-A523-F777D575DF93Q36558964-9654CEF0-3043-41F2-855D-79ACCB070282Q37636210-35DCFCB1-C8EA-43F2-A4C6-A5BC57AC47FEQ37898411-4301EDD4-6F3D-4369-B734-20B6FDF933ABQ39022962-956CC309-56E3-455C-81F6-18D2B1625882Q39904754-3F0E454B-A114-4F3F-86E8-98BFD8470572Q42210692-75B418C4-A146-4A53-BBBC-1325465A6321Q43039948-24DDAFE0-3A19-4C7F-894E-E10B7363296B
P2860
Individualisation of antiviral therapy for chronic hepatitis C.
description
2010 nî lūn-bûn
@nan
2010 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年学术文章
@wuu
2010年学术文章
@zh-cn
2010年学术文章
@zh-hans
2010年学术文章
@zh-my
2010年学术文章
@zh-sg
2010年學術文章
@yue
name
Individualisation of antiviral therapy for chronic hepatitis C.
@ast
Individualisation of antiviral therapy for chronic hepatitis C.
@en
type
label
Individualisation of antiviral therapy for chronic hepatitis C.
@ast
Individualisation of antiviral therapy for chronic hepatitis C.
@en
prefLabel
Individualisation of antiviral therapy for chronic hepatitis C.
@ast
Individualisation of antiviral therapy for chronic hepatitis C.
@en
P2093
P2860
P1476
Individualisation of antiviral therapy for chronic hepatitis C.
@en
P2093
Geoffrey C Farrell
Henry L-Y Chan
Narci C Teoh
P2860
P304
P356
10.1111/J.1440-1746.2010.06392.X
P577
2010-07-01T00:00:00Z